<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Hudson | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/zipperchin80/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/zipperchin80/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Hudson.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">e0ba41fef52faa113af9b525722bd96a</guid>
				<title>Hudson posted an update: Agmatine is a neurotransmitter with anticonvulsant, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42306/</link>
				<pubDate>Sun, 09 Feb 2025 08:48:27 -0800</pubDate>

									<content:encoded><![CDATA[<p>Agmatine is a neurotransmitter with anticonvulsant, anti-neurotoxic and antidepressant-like effects, in addition it has hypoglycemic actions. Agmatine is converted to putrescine and urea by agmatinase (AGM) and by an agmatinase-like protein (ALP), a new type of enzyme which is present in human and rodent brain tissues. Recombinant rat brain ALP is&hellip;<span class="activity-read-more" id="activity-read-more-42306"><a href="http://www.nationalboardinstitute.com/activity/p/42306/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3f5fb9f34826de6f3833d1431712b6c3</guid>
				<title>Hudson posted an update: 8, 95% CI 0.7-0.96) and teacher reports (OR 0.8, 95% CI [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41458/</link>
				<pubDate>Sat, 08 Feb 2025 09:00:48 -0800</pubDate>

									<content:encoded><![CDATA[<p>8, 95% CI 0.7-0.96) and teacher reports (OR 0.8, 95% CI 0.7-0.95). These findings were independent of psychiatric symptoms. Conclusion The relative age effects which were found in bullying involvement were independent of psychiatric symptoms. Considering this newly recognised risk factor for victimisation is important within anti-bullying&hellip;<span class="activity-read-more" id="activity-read-more-41458"><a href="http://www.nationalboardinstitute.com/activity/p/41458/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3866e19e26f7709cc8e482fc167f8818</guid>
				<title>Hudson posted an update: Conclusion There is a likely benefit to monitor DOACs in [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40674/</link>
				<pubDate>Fri, 07 Feb 2025 08:48:30 -0800</pubDate>

									<content:encoded><![CDATA[<p>Conclusion There is a likely benefit to monitor DOACs in order to improve their safety and efficacy but randomized controlled trials are required to determine the therapeutic range of these drugs and evaluate whether DOAC monitoring can improve outcomes in a clinical setting.Despite a lot of research on antiphospholipid antibodies (aPL),&hellip;<span class="activity-read-more" id="activity-read-more-40674"><a href="http://www.nationalboardinstitute.com/activity/p/40674/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">569ff682a83865acf6a266ad202cfcc8</guid>
				<title>Hudson posted an update: In contradistinction, serum uric acid (SUA) level (SMD [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39530/</link>
				<pubDate>Thu, 06 Feb 2025 08:48:23 -0800</pubDate>

									<content:encoded><![CDATA[<p>In contradistinction, serum uric acid (SUA) level (SMD -1.80, 95% CI -4.45 to 0.86) (p &gt; 0.05) and CRP levels (N = 232; SMD, -0.26; 95% CI, -0.55 to 0.04) (p &gt; 0.05) did not improve significantly. The incidence of adverse events (AEs) was not lower in the participants treated with NPDS (N = 750; RR, 0.47; 95% CI, 0.20-1.11) (p &gt; 0.05). Conclus&hellip;<span class="activity-read-more" id="activity-read-more-39530"><a href="http://www.nationalboardinstitute.com/activity/p/39530/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">77f1cb43385e791fb4ca8900e912faca</guid>
				<title>Hudson posted an update: The vascular network is a central component of the [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38032/</link>
				<pubDate>Tue, 04 Feb 2025 09:03:44 -0800</pubDate>

									<content:encoded><![CDATA[<p>The vascular network is a central component of the organ-on-a-chip system to build a 3D physiological microenvironment with controlled physical and biochemical variables. Inspired by ubiquitous biological systems such as leaf venation and circulatory systems, a fabrication strategy is devised to develop a biomimetic vascular system integrated with&hellip;<span class="activity-read-more" id="activity-read-more-38032"><a href="http://www.nationalboardinstitute.com/activity/p/38032/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">37315fab882265586bf03b198db7b68a</guid>
				<title>Hudson posted an update: Aim To describe patients' and radiographers' experiences [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37119/</link>
				<pubDate>Mon, 03 Feb 2025 09:03:00 -0800</pubDate>

									<content:encoded><![CDATA[<p>Aim To describe patients&#8217; and radiographers&#8217; experiences of abdominal compression using conventional and patient-controlled compression methods. Design Qualitative descriptive design. Methods Forty-five patients who had used both a conventional and a patient-controlled compression device answered questionnaires. Five radiographers were&hellip;<span class="activity-read-more" id="activity-read-more-37119"><a href="http://www.nationalboardinstitute.com/activity/p/37119/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8b30533992f1008491163773a2f88615</guid>
				<title>Hudson posted an update: 78, 95% CI = 0.67-0.89, sensitivity = 0.78, specificity = [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36148/</link>
				<pubDate>Sun, 02 Feb 2025 08:48:50 -0800</pubDate>

									<content:encoded><![CDATA[<p>78, 95% CI = 0.67-0.89, sensitivity = 0.78, specificity = 0.71; SVM AUC = 0.88, 95% CI = 0.78-0.98, sensitivity = 0.89, specificity = 0.79) and longitudinal PTSD symptom trajectories identified with latent growth mixture modeling (random forest AUC = 0.85, 95% CI = 0.75-0.96, sensitivity = 0.88, specificity = 0.69; SVM AUC = 0.87, 95% CI =&hellip;<span class="activity-read-more" id="activity-read-more-36148"><a href="http://www.nationalboardinstitute.com/activity/p/36148/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">56c2f157c7a6d4a6f2a7f58033f179e9</guid>
				<title>Hudson posted an update: Superconcentrated aqueous electrolytes ("water-in-salt" [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34458/</link>
				<pubDate>Fri, 31 Jan 2025 08:59:11 -0800</pubDate>

									<content:encoded><![CDATA[<p>Superconcentrated aqueous electrolytes (&#8220;water-in-salt&#8221; electrolytes, or WiSEs) enable various aqueous battery chemistries beyond the voltage limits imposed by the Pourbaix diagram of water. However, their detailed structural and transport properties remain unexplored and could be better understood through added studies. Here, we report on our&hellip;<span class="activity-read-more" id="activity-read-more-34458"><a href="http://www.nationalboardinstitute.com/activity/p/34458/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0220896c295a03eb3e52efc51f9671f4</guid>
				<title>Hudson posted an update: 5 μg/mL). Our findings suggest that α-triazolylboronates m [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30886/</link>
				<pubDate>Tue, 28 Jan 2025 15:53:39 -0800</pubDate>

									<content:encoded><![CDATA[<p>5 μg/mL). Our findings suggest that α-triazolylboronates might represent an effective scaffold for the treatment of KPC-mediated infections.Varicocele (VC) is the most common treatable cause of infertility, but it is difficult to distinguish fertile from infertile VC populations because the pathogenesis is unclear. In order to study the related m&hellip;<span class="activity-read-more" id="activity-read-more-30886"><a href="http://www.nationalboardinstitute.com/activity/p/30886/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fed719be838b61c9764f74d2df666876</guid>
				<title>Hudson became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30818/</link>
				<pubDate>Tue, 28 Jan 2025 15:46:45 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>